在心脏性休克早期再血管化后的一年生存率为心脏性休克
J S Hochman1, L A Sleeper, H D White
1St Luke's-Roosevelt Hospital Center, 1111 Amsterdam Ave, New York, NY 10025, USA.
JAMA
|February 15, 2001
概括
早期的再血管化显著改善了急性心肌梗塞患者心脏性休克的1年生存率. 这种干预措施对75岁以下的人特别有益.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 心脏性休克 (CS) 是急性心肌梗塞 (AMI) 住院患者的主要死亡原因.
- 有效的AMI诱导的CS管理策略对于改善患者的治疗结果至关重要.
研究的目的:
- 评估早期复血管化的影响 (ERV) 对经历AMI并发症的患者的1年生存率.
- 在这个高风险患者群体中,比较ERV与初始医疗稳定 (IMS) 的疗效.
主要方法:
- 该研究涉及302名AMI和CS患者,随机分配到ERV组或IMS组.
- ERV组在6小时内进行了再血管化,而IMS组在某些情况下接受了医疗稳定,并推迟了再血管化.
- 评估的结果包括所有原因的死亡率和1年后的功能状态.
主要成果:
- 与IMS组相比,ERV组的一年生存率 (46.7%) 显著高于IMS组 (33.6%).
- 在75岁以下的患者中观察到显著的治疗益处.
- 在这两组中,大多数1年幸存者都属于纽约心脏协会的功能类I或II.
结论:
- 早期的再血管化改善了由CS复杂的AMI患者的1年生存率.
- 对于这些患者,特别是75岁以下的患者,建议迅速转移到能够进行早期血管造影和再血管化的中心.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Cardiopulmonary Resuscitation I: Adult
1.3K
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K


